A new study reports that chronic kidney disease (CKD) may speed up cognitive decline, and its impact varies significantly between men and women. Researchers found that this decline largely stems from damage to the “heart–brain link” caused by long-standing kidney illness.
Men Show Greater Cognitive and Cardiac Impairment
Studying a rural U.S. population, scientists from Marshall University discovered that men with CKD experienced more severe cognitive impairment than women. Moreover, men showed a more pronounced reduction in heart function, reinforcing a stronger connection between heart damage and cognitive decline in male patients.
Study Highlights Sex-Specific Biological Pathways
Published in the American Journal of Physiology – Heart and Circulatory Physiology, the findings reveal that men may face more adverse cognitive outcomes due to distinct biological pathways linking the kidney, heart, and brain. Lead author Sneha S. Pillai noted that these pathways operate differently in men and women, underscoring the need for sex-informed medical approaches.
Elevated Blood Pressure and Reduced Heart Function in Male CKD Patients
As reported by NDTV, the authors reported that CKD patients had higher blood pressure compared to individuals without the disease. Additionally, men showed a clear decline in cardiac function when compared with age- and sex-matched controls. The study evaluated a community-dwelling rural population to better understand sex-specific communication within the kidney-heart-brain axis.
Implications for Early Diagnosis and Treatment
The researchers emphasized that these insights explain why men often experience more severe neurological effects from CKD. Consequently, the findings point to potential sex-specific targets for early diagnosis and personalized treatment strategies.
Call for Tailored Medical Interventions
Lead researcher Komal Sodhi stressed the urgency of developing customized prevention strategies to stop CKD patients from progressing to serious neurological disorders. She added that understanding sex-dependent differences in disease mechanisms could pave the way for innovative therapies.